Ocugen Inc (OCGN)
0.9652
-0.03
(-3.48%)
USD |
NASDAQ |
Nov 15, 10:51
Ocugen Cash from Investing (Quarterly): -0.513M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.513M |
| March 31, 2024 | -2.352M |
| December 31, 2023 | -2.722M |
| September 30, 2023 | -3.365M |
| June 30, 2023 | 5.723M |
| March 31, 2023 | 3.441M |
| December 31, 2022 | -15.30M |
| September 30, 2022 | -0.083M |
| June 30, 2022 | -1.366M |
| March 31, 2022 | -0.223M |
| December 31, 2021 | -0.192M |
| September 30, 2021 | -0.35M |
| June 30, 2021 | -1.013M |
| March 31, 2021 | -0.261M |
| December 31, 2020 | -0.251M |
| September 30, 2020 | -0.022M |
| June 30, 2020 | 0.019M |
| March 31, 2020 | -0.053M |
| December 31, 2019 | -0.0209M |
| September 30, 2019 | -2.446M |
| June 30, 2019 | 0.11M |
| Date | Value |
|---|---|
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.073M |
| September 30, 2018 | 0.794M |
| June 30, 2018 | -1.479M |
| March 31, 2018 | -0.355M |
| December 31, 2017 | 0.747M |
| September 30, 2017 | 6.104M |
| June 30, 2017 | -0.038M |
| March 31, 2017 | -8.043M |
| December 31, 2016 | -0.003M |
| September 30, 2016 | -0.003M |
| June 30, 2016 | -0.282M |
| March 31, 2016 | -0.032M |
| December 31, 2015 | -0.131M |
| September 30, 2015 | -0.498M |
| June 30, 2015 | -0.405M |
| March 31, 2015 | -0.915M |
| December 31, 2014 | -1.744M |
| September 30, 2014 | -1.384M |
| June 30, 2014 | -0.073M |
| March 31, 2014 | -0.12M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-15.30M
Minimum
Dec 2022
5.723M
Maximum
Jun 2023
-0.9947M
Average
-0.251M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| Cytokinetics Inc | -45.05M |
| Scholar Rock Holding Corp | 50.62M |
| Mirum Pharmaceuticals Inc | -72.72M |
| SpringWorks Therapeutics Inc | 0.289M |
| NeuroBo Pharmaceuticals Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.911M |
| Cash from Financing (Quarterly) | 0.045M |
| Free Cash Flow | -54.47M |
| Free Cash Flow Per Share (Quarterly) | -0.0405 |
| Free Cash Flow to Equity (Quarterly) | -10.45M |
| Free Cash Flow Yield | -21.29% |